Sort   by:  
 Page size 
UnknownComprehensive and quantitative urinary metabolomic profiling for improved characterization of diabetic nephropathy.
Not available
S-EPMC12619831 | biostudies-literature
UnknownTranscriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.
Not available
S-EPMC5870959 | biostudies-literature
UnknownEffectiveness of a low-fructose and/or low-sucrose diet in decreasing insulin resistance (DISFRUTE study): study protocol for a randomized controlled trial.
Not available
S-EPMC5547514 | biostudies-literature
UnknownMaraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Not available
S-EPMC5853584 | biostudies-literature
UnknownOutcomes of urgent gastrointestinal-related procedures in Latin America (LATAM-URG): a prospective multicentre study.
Not available
S-EPMC12921494 | biostudies-literature
UnknownA second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
Sort   by:  
 Page size